Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles

Biochemistry

Volumn 52, Issue 37, 2013, Pages 6324-6334

  Yao, Hongwei ^a,d   Mi, Shuofu ^b   Gong, Weibin ^a   Lin, Jian ^b   Xu, Nuo ^b   Perrett, Sarah ^a   Xia, Bin ^b   Wang, Jinfeng ^a   Feng, Yingang ^a,c  

^a INSTITUTE OF BIOPHYSICS   (China)

^b PEKING UNIVERSITY   (China)

^c QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY   (China)

^d TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING AFFINITIES; DISSOCIATION CONSTANT; DNA-BINDING DOMAIN; INTERACTION MECHANISMS; ISOTHERMAL TITRATION CALORIMETRY; PHYSICAL INTERACTIONS; TRANSACTIVATION DOMAIN; TUMOR SUPPRESSORS;

BINDING ENERGY; CELL DEATH; DISSOCIATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TITRATION; TRANSCRIPTION;

PROTEINS;

BH3 PROTEIN; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN P53;

ARTICLE; BINDING AFFINITY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYTOSOL; DISSOCIATION CONSTANT; HETERONUCLEAR SINGLE QUANTUM COHERENCE; ISOTHERMAL TITRATION CALORIMETRY; NITROGEN NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSACTIVATION;

AMINO ACID SEQUENCE; BCL-X PROTEIN; CALORIMETRY; HUMANS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884274803     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi400690m     Document Type: Article

References (44)

1. Riley, T., Sontag, E., Chen, P., and Levine, A. (2008) Transcriptional control of human p53-regulated genes Nat. Rev. Mol. Cell Biol. 9, 402-412 (Pubitemid 351574202)
2. Vousden, K. H. and Prives, C. (2009) Blinded by the light: The growing complexity of p53 Cell 137, 413-431
3. Speidel, D. (2010) Transcription-independent p53 apoptosis: an alternative route to death Trends Cell Biol. 20, 14-24
4. Chipuk, J. E. and Green, D. R. (2003) p53's believe it or not: Lessons on transcription-independent death J. Clin. Immunol. 23, 355-361 (Pubitemid 37083189)
5. Vaseva, A. V. and Moll, U. M. (2009) The mitochondrial p53 pathway Biochim. Biophys. Acta, Bioenerg. 1787, 414-420
6. Green, D. R. and Kroemer, G. (2009) Cytoplasmic functions of the tumour suppressor p53 Nature 458, 1127-1130
7. Youle, R. J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death Nat. Rev. Mol. Cell Biol. 9, 47-59
8. Danial, N. N. (2007) BCL-2 family proteins: Critical checkpoints of apoptotic cell death Clin. Cancer. Res. 13, 7254-7263
9. Leu, J. I. J., Dumont, P., Hafey, M., Murphy, M. E., and George, D. L. (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex Nat. Cell Biol. 6, 443-450 (Pubitemid 38607505)
10. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D., Schuler, M., and Green, D. R. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis Science 303, 1010-1014 (Pubitemid 38209704)
11. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., and Moll, U. M. (2003) p53 has a direct apoptogenic role at the mitochondria Mol. Cell 11, 577-590 (Pubitemid 36385115)
12. Han, J., Goldstein, L. A., Hou, W., Gastman, B. R., and Rabinowich, H. (2010) Regulation of mitochondrial apoptotic events by p53-mediated disruption of complexes between anti-apoptotic Bcl-2 members and Bim J. Biol. Chem. 285, 22473-22483
13. Fire, E., Gulla, S. V., Grant, R. A., and Keating, A. E. (2010) Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes Protein Sci. 19, 507-519
14. Thomas, L. W., Lam, C., and Edwards, S. W. (2010) Mcl-1; the molecular regulation of protein function FEBS Lett. 584, 2981-2989
15. Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., and Huang, D. C. S. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function Mol. Cell 17, 393-403 (Pubitemid 40193310)
16. Dutta, S., Gulla, S., Chen, T. S., Fire, E., Grant, R. A., and Keating, A. E. (2010) Determinants of BH3 binding specificity for Mcl-1 versus BcI-x(L) J. Mol. Biol. 398, 747-762
17. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B. L., Wendt, M. D., Zhang, H. C., Fesik, S. W., and Rosenberg, S. H. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435, 677-681 (Pubitemid 40825512)
18. van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., Adams, J. M., Roberts, A. W., and Huang, D. C. S. (2006) The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized Cancer Cell 10, 389-399 (Pubitemid 44711953)
19. Deng, J., Carlson, N., Takeyama, K., Dal Cin, P., Shipp, M., and Letai, A. (2007) BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents Cancer Cell 12, 171-185 (Pubitemid 47199122)
20. Vikstrom, I., Carotta, S., Luthje, K., Peperzak, V., Jost, P. J., Glaser, S., Busslinger, M., Bouillet, P., Strasser, A., Nutt, S. L., and Tarlinton, D. M. (2010) Mcl-1 is essential for germinal center formation and B cell memory Science 330, 1095-1099
21. Germain, M., Nguyen, A. P., Le Grand, J. N., Arbour, N., Vanderluit, J. L., Park, D. S., Opferman, J. T., and Slack, R. S. (2011) MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner EMBO J. 30, 395-407
22. Weng, S. Y., Yang, C. Y., Li, C. C., Sun, T. P., Tung, S. Y., Yen, J. J. Y., Tsai, T. F., Chen, C. M., Chen, S. H., Hsiao, M., Huang, P. H., and Yang-Yen, H. F. (2011) Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancer J. Hepatol. 54, 685-694
23. Xu, H. B., Tai, J., Ye, H., Kang, C. B., and Yoon, H. S. (2006) The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl Biochem. Biophys. Res. Commun. 341, 938-944 (Pubitemid 43221756)
24. Hagn, F., Klein, C., Demmer, O., Marchenko, N., Vaseva, A., Moll, U. M., and Kessler, H. (2010) BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain J. Biol. Chem. 285, 3439-3450
25. Petros, A. M., Gunasekera, A., Xu, N., Olejniczak, E. T., and Fesik, S. W. (2004) Defining the p53 DNA-binding domain/Bcl-XL-binding interface using NMR FEBS Lett. 559, 171-174 (Pubitemid 38186723)
26. Xu, H. B., Ye, H., Osman, N. E., Sadler, K., Won, E. Y., Chi, S. W., and Yoon, H. S. (2009) The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif Biochemistry 48, 12159-12168
27. Ha, J. H., Won, E. Y., Shin, J. S., Jang, M., Ryu, K. S., Bae, K. H., Park, S. G., Park, B. C., Yoon, H. S., and Chi, S. W. (2011) Molecular mimicry-based repositioning of Nutlin-3 to anti-apoptotic Bcl-2 family proteins J. Am. Chem. Soc. 133, 1244-1247
28. Cheng, Y. and Patel, D. J. (2004) An efficient system for small protein expression and refolding Biochem. Biophys. Res. Commun. 317, 401-405 (Pubitemid 38452497)
29. Yao, H. W., Feng, Y. G., Zhou, T., Wang, J. F., and Wang, Z. X. (2012) NMR studies of the interaction between human programmed cell death 5 and human p53 Biochemistry 51, 2684-2693
30. Johnson, B. A. and Blevins, R. A. (1994) NMRView-a computer program for the visualization and analysis of NMR data J. Biomol. NMR 4, 603-614
31. Lei, X. B., Chen, Y. Y., Du, G. H., Yu, W. Y., Wang, X. H., Qu, H., Xia, B., He, H. P., Mao, J. H., Zong, W. X., Liao, X. D., Mehrpour, M., Hao, X. J., and Chen, Q. (2006) Gossypol induces Bax/Bak-independent activation of apoptosis and cytochrome c release via a conformational change in Bcl-2 FASEB J. 20, 2147-2149
32. Liu, Q., Moldoveanu, T., Sprules, T., Matta-Camacho, E., Mansur-Azzam, N., and Gehring, K. (2010) Apoptotic regulation by MCL-1 through heterodimerization J. Biol. Chem. 285, 19615-19624
33. Grzesiek, S., Stahl, S. J., Wingfield, P. T., and Bax, A. (1996) The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR Biochemistry 35, 10256-10261 (Pubitemid 26277283)
34. Fielding, L. (2007) NMR methods for the determination of protein-ligand dissociation constants Prog. Nucl. Magn. Reson. Spectrosc. 51, 219-242 (Pubitemid 350064300)
35. Day, C. L., Chen, L., Richardson, S. J., Harrison, P. J., Huang, D. C. S., and Hinds, M. G. (2005) Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands J. Biol. Chem. 280, 4738-4744 (Pubitemid 40288644)
36. Sali, A. and Blundell, T. L. (1993) Comparative protein modeling by satisfaction of spatial restraints J. Mol. Biol. 234, 779-815 (Pubitemid 24007801)
37. Sot, B., Freund, S. M. V., and Fersht, A. R. (2007) Comparative biophysical characterization of p53 with the proapoptotic BAK and the antiapoptotic BCL-x(L) J. Biol. Chem. 282, 29193-29200 (Pubitemid 350043367)
38. Chipuk, J. E., Bouchier-Hayes, L., Kuwana, T., Newmeyer, D. D., and Green, D. R. (2005) PUMA couples the nuclear and cytoplasmic pro-apoptotic function of p53 Science 309, 1732-1735 (Pubitemid 41285944)
39. Tomita, Y., Marchenko, N., Erster, S., Nemajerova, A., Dehner, A., Klein, C., Pan, H. G., Kessler, H., Pancoska, P., and Moll, U. M. (2006) WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization J. Biol. Chem. 281, 8600-8606 (Pubitemid 43847963)
40. Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., and Pavletich, N. P. (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain Science 274, 948-953 (Pubitemid 26398409)
41. Joerger, A. C. and Fersht, A. R. (2010) The tumor suppressor p53: from structures to drug discovery Cold Spring Harbor Perspect. Biol. 2, a000919
42. Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., and Green, D. R. (2010) The BCL-2 Family Reunion Mol. Cell 37, 299-310
43. Quinn, B. A., Dash, R., Azab, B., Sarkar, S., Das, S. K., Kumar, S., Oyesanya, R. A., Dasgupta, S., Dent, P., Grant, S., Rahmani, M., Curiel, D. T., Dmitriev, I., Hedvat, M., Wei, J., Wu, B., Stebbins, J. L., Reed, J. C., Pellecchia, M., Sarkar, D., and Fisher, P. B. (2011) Targeting Mcl-1 for the therapy of cancer Expert Opin. Invest. Drugs 20, 1397-1411
44. Zhang, Z., Yang, H., Wu, G., Li, Z., Song, T., and Li, X. Q. (2011) Probing the difference between BH3 groove of Mcl-1 and Bcl-2 protein: Implications for dual inhibitors design Eur. J. Med. Chem. 46, 3909-3916